Exploring Molecular Testing For Nsclc In 2017
Exploring Molecular Testing For Nsclc In 2017 reveals several interesting facts.
- Philip C. Mack, PhD, identifies the importance of
- In this segment, John Fox, MD, MHA, discusses the utility of
- Lung Cancer
- Julie R. Brahmer, MD, co-director of the Upper Aerodigestive Department in the Bloomberg-Kimmel Institute for Cancer ...
- Jared Weiss, MD; Gregory J. Riely, MD, PhD; and Greg Riedlinger, MD, PhD, reflect on recent advances in
In-Depth Information on Molecular Testing For Nsclc In 2017
Panelists Mark Socinski, MD, and Alexander Drilon, MD, discuss the use of comprehensive Roy S. Herbst, MD, PhD, provides insight on the importance of Recommendations for For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Fred R. Hirsch, MD, PhD, professor of Medicine, University of Colorado Denver, discusses the importance of
Stay tuned for more updates related to Molecular Testing For Nsclc In 2017.